←
Keshari Lab644 posts
Keshari Lab avatar

Keshari Lab

@KeshariLab

Harnessing cancer metabolism and metabolic aberrations @sloan_kettering to develop new imaging and therapeutic strategies. Opinions are our own.

◷ Joined April 2017▧ 29 Photos and videos
Memorial Sloan Kettering Cancer Center avatar
⟳ Keshari Lab retweeted
Memorial Sloan Kettering Cancer Center@MSKCancerCenter·23h

🚨 A new cancer vaccine appears to significantly improve survival in people in remission from acute myeloid leukemia (AML), according to new results from a phase 3 clinical trial. The vaccine, galinpepimut-S (GPS), is an “off-the-shelf” vaccine invented by MSK leukemia specialist and physician-scientist Dr. David A. Scheinberg (@DASLab_MSKCC). In the trial of 126 patients, it reduced the risk of death by 41%. Median overall survival was 24.0 months with the vaccine compared with 14.7 months for patients on standard treatments. “These data bring us closer to having the first off-the-shelf vaccine for AML patients." Learn more: bit.ly/4fDoAmS

Post attachment
AACR avatar
⟳ Keshari Lab retweeted
AACR@AACR·Oct 27

Register by December 2 to get the lowest rates for the AACR Conference on Cancer Biology-informed Radioligand Therapy (Jan 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson. brnw.ch/21x6Ihk #aacrRLT27 @KeshariLab

Post attachment
AACR avatar
⟳ Keshari Lab retweeted
AACR@AACR·Oct 20

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson. brnw.ch/21x6y52 #aacrRLT27 @KeshariLab

Post attachment
Keshari Lab avatar
Keshari Lab@KeshariLab·Oct 2

This work started when Andrew Cho joined the lab, asking if we could leverage arginine metabolism for in vivo metabolic tracing, building some really interesting findings. Stay tuned for where ornithine goes next…

Keshari Lab avatar
Keshari Lab@KeshariLab·Oct 2

Congrats to @Nancy_T_S for pulling together and leading this great collaborative effort between our lab and @JustinPerryPhD! Here we build more on the concept of metabolic symbiosis… science.org/doi/10.1126/scia…

AACR avatar
⟳ Keshari Lab retweeted
AACR@AACR·Sep 25

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson. brnw.ch/21x5XW9 #aacrRLT26 @KeshariLab

Post attachment
AACR avatar
⟳ Keshari Lab retweeted
AACR@AACR·Sep 3

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson. brnw.ch/21x5qeO #aacrRLT26 @KeshariLab

Post attachment
Kentsis Research Group avatar
⟳ Keshari Lab retweeted
Kentsis Research Group@KentsisResearch·Sep 3

Read our latest: Recurrent non-canonical proteoforms in acute myeloid leukemia identified by integrative proteogenomics biorxiv.org/content/10.64898…

AACR avatar
⟳ Keshari Lab retweeted
AACR@AACR·Aug 25

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson. brnw.ch/21x5caV #aacrRLT26 @juliesut8

Post attachment
AACR avatar
⟳ Keshari Lab retweeted
AACR@AACR·Aug 11

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson. brnw.ch/21x4QzA #aacrRLT26 @KeshariLab

Post attachment
Keshari Lab avatar
Keshari Lab@KeshariLab·Aug 8

Congrats to Briana for defending her PhD, so many amazing directions all coming together! Especially being able to bridge @KeshariLab and @KharasLab. We are looking forward to the things you do next.

Post attachmentPost attachment
AACR avatar
⟳ Keshari Lab retweeted
AACR@AACR·Jul 20

Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson. brnw.ch/21x4hB6 #aacrRLT26 @KeshariLab

Post attachment